{
    "nctId": "NCT05622617",
    "briefTitle": "Relationship Between Serum Interleukin-20 Level and Paclitaxel-associated Neuropathy",
    "officialTitle": "Prospective Observational Investigation of Serum Interleukin-20 Level and Paclitaxel-Associated Neuropathy in Breast Cancer Patients Receiving Paclitaxel Chemotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Neuropathy Associated With Dysproteinaemias",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Relationship with paclitaxel associated neuropathy and serum IL-20 level",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients receiving paclitaxel chemotherapy for local advanced or early-stage breast cancer\n* \\>18 years\n\nExclusion Criteria:\n\n* advanced stage breast cancer\n* having before peripheral neuropathy\n* patients with diabetes mellitus\n* \\< 18 years",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}